Tow early adopters of METAFORA biosystems products published articles in November. We are proud to now aknowledge over 18 publications reporting the use of RBDs !
Puleston et al, Autophagy is a critical regulator of memory CD8(+) T cell formation. Elife 2014.
Hegedus et al, HIV-1 pathogenicity and virions production are dependent on the metabolic phenotype of activated CD4+ T cells. Retrovirology 2014.
OZYME grant exclusive sales rights in France and non-exclusive in European Union.
METAFORA biosystems announced today the signature of a distributorship agreement with OZYMEto commercialize its newly developed series of METAscreen® kits for research. OZYME granted exclusive sales rights in France and non-exclusive in European Union.
Specialist since 1984 in the commercialization of research laboratory products, OZYME offers markets products under its own brand and selected partners.
Headquartered near Paris, OZYME team is composed of forty employees, half of them being scientists, PhDs or graduated from engineering school. Sea more on OZYME website at www.ozyme.fr